IDEXX LABORATORIES INC /DE (IDXX) Cost of Revenue USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Idexx Laboratories Inc /De quarterly/annual Cost of Revenue history and growth rate from 2010 to 2024.
  • Idexx Laboratories Inc /De Cost of Revenue for the quarter ending March 31, 2024 was $371 M, a 3.86% increase year-over-year.
  • Idexx Laboratories Inc /De Cost of Revenue for the twelve months ending March 31, 2024 was $1.48 B, a 7.41% increase year-over-year.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2023 was $1.47 B, a 7.92% increase from 2022.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2022 was $1.36 B, a 2.8% increase from 2021.
  • Idexx Laboratories Inc /De annual Cost of Revenue for 2021 was $1.33 B, a 16.8% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.48 B $371 M +$13.8 M +3.86% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.47 B $375 M +$31.8 M +9.25% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.44 B $368 M +$32.5 M +9.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $1.41 B $371 M +$24.3 M +7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $1.38 B $357 M +$19.4 M +5.75% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $1.36 B $344 M -$1.03 M -0.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $1.36 B $335 M -$2.47 M -0.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $1.37 B $347 M +$9.68 M +2.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $1.36 B $338 M +$30.9 M +10.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $1.33 B $345 M +$33.2 M +10.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $1.29 B $338 M +$38.3 M +12.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $1.25 B $337 M +$78.6 M +30.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $1.18 B $307 M +$40.2 M +15.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $1.14 B $311 M +$37.1 M +13.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $1.1 B $299 M +$38.8 M +14.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $1.06 B $258 M -$4 M -1.53% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $1.06 B $267 M +$22.3 M +9.12% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.04 B $274 M +$25.3 M +10.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $1.02 B $260 M +$20.5 M +8.57% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $996 M $262 M +$13.9 M +5.61% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $982 M $244 M +$9.9 M +4.22% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $972 M $249 M +$15.4 M +6.58% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $956 M $240 M +$21.8 M +10% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $934 M $248 M +$32.1 M +14.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $902 M $235 M +$30.7 M +15.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $872 M $234 M +$31.3 M +15.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $840 M $218 M +$16.4 M +8.13% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $824 M $216 M +$10.2 M +4.95% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $814 M $204 M +$13.8 M +7.27% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $800 M $202 M +$20.4 M +11.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 $780 M $202 M +$19.5 M +10.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $760 M $206 M +$25.4 M +14.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $735 M $190 M +$23.1 M +13.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $712 M $182 M +$12.2 M +7.18% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $699 M $182 M +$11.9 M +7.01% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $688 M $181 M +$8.98 M +5.23% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $679 M $167 M +$8.83 M +5.58% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $670 M $170 M +$4.39 M +2.65% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $665 M $170 M +$17.7 M +11.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $648 M $172 M +$16.7 M +10.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $631 M $158 M +$9.97 M +6.73% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $621 M $165 M +$14.9 M +9.92% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-17
Q3 2013 $606 M $153 M +$7.67 M +5.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $598 M $155 M +$3.93 M +2.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-25
Q1 2013 $594 M $148 M +$230 K +0.16% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q4 2012 $594 M $150 M +$2.17 M +1.46% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-17
Q3 2012 $592 M $145 M +$2.55 M +1.79% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-22
Q2 2012 $589 M $151 M +$7.13 M +4.96% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-23
Q1 2012 $582 M $148 M +$10.2 M +7.37% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 $572 M $148 M +$9.33 M +6.72% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-18
Q3 2011 $563 M $142 M +$14.9 M +11.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-19
Q2 2011 $548 M $144 M +$11.6 M +8.8% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-20
Q1 2011 $536 M $138 M +$11.6 M +9.18% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q4 2010 $525 M $139 M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-19
Q3 2010 $127 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-21
Q2 2010 $132 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-22
Q1 2010 $126 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.